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Polyomavirus-associated nephropathy (PVAN) is a significant
complication after kidney transplantation, often leading to
premature graft loss. In order to identify antiviral responses
of the renal tubular epithelium, we studied activation of the
viral DNA and the double-stranded RNA (dsRNA) sensors
Toll-like receptor 3 (TLR3) and retinoic acid inducible gene-I
(RIG-I) in allograft biopsy samples of patients with PVAN, and
in human collecting duct cells in culture after stimulation
by the dsRNA mimic polyriboinosinic:polyribocytidylic acid
(poly(I:C)), cytokines, or infection with BK virus. Double
staining using immunofluorescence for BK virus and TLR3
showed strong signals in epithelial cells of distal cortical
tubules and the collecting duct. In biopsies microdissected to
isolate tubulointerstitial lesions, TLR3 but not RIG-I mRNA
expression was found to be increased in PVAN. Collecting
duct cells in culture expressed TLR3 intracellularly, and
activation of TLR3 and RIG-I by poly(I:C) enhanced expression
of cytokine, chemokine, and IFN-b mRNA. This inflammatory
response could be specifically blocked by siRNA to TLR3.
Finally, infection of the collecting duct cells with BK virus
enhanced the expression of cytokines and chemokines. This
led to an efficient antiviral immune response with TLR3 and
RIG-I upregulation without activation of IL-1b or components
of the inflammasome pathway. Thus, PVAN activation of
innate immune defense mechanisms through TLR3 is involved
in the antiviral and anti-inflammatory response leading to the
expression of proinflammatory cytokines and chemokines.
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Polyomavirus-associated nephropathy (PVAN) is an emerg-
ing cause of significant kidney transplant dysfunction
affecting up to 10% of organ recipients, often leading to
graft loss. Most cases of PVAN are elicited by BK virus (BKV)
in the context of intense immunosuppression. As no specific
antiviral drug is available to date, the primary treatment for
PVAN is reduction of immunosuppression, which must be
carefully balanced against increased risks of acute rejection
(AR).1,2
BKV normally replicates in urothelial cells, which remains
asymptomatic in two-thirds of infected patients after kidney
transplantation,3 but it can exhibit tropism for the renal
tubular epithelium, which may be latently infected.4
The renal involvement in PVAN is multifocal, and distal
nephron segments, that is, medullary collecting ducts and
distal cortical tubules, are usually more severely affected than
proximal segments.5 To achieve a productive infection, the
BKV genome has to be delivered to the nucleus, where early
genes are expressed, followed by DNA replication, late protein
expression, and virion assembly. Histologically, viral replication
results in tubular epithelial cell enlargement, karyomegaly, and
nuclear inclusion bodies. These cytopathic changes are often
associated with death of tubular epithelial cells, denudation of
the basement membrane, and a strong interstitial inflamma-
tory response, similar to that seen in acute interstitial rejection.
Histological diagnosis of PVAN requires evaluation of a renal
biopsy with demonstration of cytopathic changes and
confirmation by immunohistochemistry.6
The molecular events involved in BKV invasion of host
cells and subsequent intracellular trafficking are an important
area of study. In various cell culture models, BKV uses an
N-linked glycoprotein containing an a(2,3)-linked sialic acid
as a receptor and enters cells through caveola-mediated
endocytosis.7,8 After this relatively slow and cholesterol-
dependent internalization, BKV migrates through the
cytoplasm and via cellular components to the nucleus, where
viral transcription, replication, and assembly take place. The
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innate immune system has a critical role in recognizing viral
infections and evoking initial antiviral responses. Viruses are
sensed via their nucleic acid genome or as a result of their
replicative or transcriptional activity.9 Several classes of
receptors sense cytosolic viral components, such as double-
stranded RNA (dsRNA), single-stranded RNA (ssRNA), and
ds or ss DNA. These include retinoic acid-inducible gene I
(RIG-I)-like receptors, Toll-like receptors (TLRs), nucleotide
oligomerization domain-like receptors, and cytosolic DNA
sensors.10,11 Recognition by these sensors induces the
production of type I interferons (IFNs) and the assembly of
inflammasome complexes that activate caspase-1, leading to
production of interleukin-1b (IL-1b) and IL-18.12,13
For polyomavirus BK, dsDNA and dsRNA are critical
targets. The dsRNA is a molecular pattern associated with
viral infection, because it is produced by most viruses at some
point during their replication.14 The recognition of viral
dsRNA triggers downstream signaling cascades leading to the
activation of nuclear factor (NF)-kB, and induces antiviral
mediators such as type I IFNs and proinflammatory
cytokines.15,16 RIG-I is a highly inducible cytoplasmic RNA
helicase that signals antiviral responses after binding dsRNA
and ssRNA containing a 50 triphosphate. This pathway has
been implicated in antiviral responses to Sendai virus,
vesicular stomatitis virus, Newcastle disease virus, as well as
different flaviviruses and Kaposi’s sarcoma-associated her-
pesvirus.17–19 In addition, Chiu et al.20 recently demonstrated
that a cytosolic B form of dsDNA, poly (dA-dT)  poly (dA-
dT), is able to activate RIG-I and induce IFN-b production
via the cytosolic DNA-dependent RNA polymerase III
(PolIII).
Because of the above-mentioned characteristics involved
in BKV invasion of host cells and subsequent intracellular
trafficking, we restricted our search for TLR candidates that
could be involved in PVAN to those intracellular TLRs that
sense nucleic acids in endosomal compartments. This latter
group includes TLR3, TLR7, TLR8, and TLR9. Whereas
TLR7 and TLR8 recognize ssRNA and TLR9 specifically binds
CpG DNA motifs and has a significant role in the
development of tubulointerstitial injury in systemic lupus,21
TLR3 recognizes viral dsRNA, which is generated during the
life cycle of many viruses, and its synthetic analog
polyriboinosinic:polyribocytidylic acid (poly(I:C)).22,23
TLR3 senses dsRNA through its unique adaptor protein
TIR-domain-containing adapter-inducing interferon-b
(TRIF).24 Recognition of viral RNA by TLR3 triggers
activation of the transcription factors NF-kB and interferon
regulatory factor 3 and induction of type I IFNs, which are
critical for cellular antiviral responses.
We hypothesized that particularly TLR3 could be a
receptor candidate to mediate activation of innate immunity
in PVAN. Our hypothesis was underscored by two recent
findings. (1) TLR3 resides in the endosomal membrane and
the endoplasmic reticulum and moves to dsRNA-containing
endosomes in response to dsRNA.25 As BKV has previously
been shown to enter cells through endocytosis, viral dsRNAs
could activate TLR3 during BKV infection of tubular
epithelial cells upon viral entry and uncoating in the
endosome. (2) Upregulation of the TLR3 pathway was
reported in response to various viruses containing a dsDNA
genome, for example, Kaposi’s sarcoma-associated herpes-
virus,26 HSV-1,27,28 and murine CMV.29
Here we examined the activation of TLR3 and RIG-I in
allograft biopsy samples of PVAN and in human collecting
duct cells after poly(I:C) and cytokine stimulation, as well as
after infection with BKV. Our findings indicate that
activation of innate immune defense mechanisms, that is,
TLR3, contributes to the inflammation in PVAN.
RESULTS
In biopsies with PVAN staining for polyomavirus (anti-SV40)
and TLR3 colocalized in epithelial cells of cortical tubules and
the collecting duct
Polyomavirus BK exhibits a tropism for the renal tubular
epithelium, particularly in distal nephron segments. Immu-
nofluorescence double staining (Figure 1) for the SV40 large
T antigen (T-Ag) of polyomavirus and TLR3 in allograft
biopsies with histological diagnosis of PVAN showed
Overlay
TLR3 SV40
Figure 1 | Immunofluorescence double staining for Toll-like
receptor 3 (TLR3) and SV40 in human kidney biopsies with
clinical and histological diagnosis of polyomavirus-associated
nephropathy (PVAN): colocalization of polyomavirus
(anti-SV40) and TLR3 protein expression in epithelial cells
of distal cortical tubules and the collecting duct. Double
immunofluorescence staining of paraffin-embedded tissue
sections of kidney needle biopsies from individuals with PVAN.
Colocalization of nuclear signals for polyomavirus (SV40, green)
and intracytoplasmatic signals for TLR3 (red) in tubular epithelial
cells of distal cortical tubules and the collecting duct.
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colocalization of nuclear signals for polyomavirus and
intracytoplasmatic signals for TLR3 in epithelial cells of
distal cortical tubules and the collecting duct. Intensity of
immunofluorescence signals and SV40/TLR3 colocalization
was semiquantitatively and separately assessed in medullary
collecting ducts and cortical tubules. The results are
summarized in Table 1. In general, we found a great variation
in SV40 and TLR3 signal intensity in the different biopsies,
with an overall most intense TLR3 staining in medullary
collecting ducts of PVAN. Highest semiquantitative SV40/
TLR3 colocalization rates (partially 475%) were found in
collecting ducts of the medulla in biopsies with few
interstitial infiltrates. TLR staining in renal transplant
biopsies without BKV infection was significantly less intense
than in PVAN, and revealed a more cortical accentuated
pattern with a most prominent TLR3 expression in cortical
atrophic and dilated tubules.
TLR3 mRNA expression, but not RIG-I mRNA expression, is
significantly induced in biopsies with PVAN compared with
allograft biopsies with ongoing AR
We found a significant induction of TLR3 mRNA expression
in the tubulointerstitial compartment of PVAN compared
with renal allograft biopsies with AR and pretransplant
donor biopsies. Despite similar inflammatory infiltrates by
immunohistochemical analysis (see Supplementary Table S1
online), the increased expression of TLR3 mRNA in PVAN
clearly differentiated them from those with AR (Figure 2a). In
contrast, in renal allograft biopsies with AR, RIG-I mRNA
expression was significantly induced compared with PVAN
and controls (Figure 2b). As expected, according to the
equally intense inflammatory infiltrate, the mRNA expression
of CCL5 (chemokine (C-C motif) ligand 5)/RANTES
(regulated upon activation, normal T cell expressed and
secreted) was significantly upregulated in both AR and PVAN
when compared with controls (Figure 2c).
Expression of TLR3 and RIG-I protein and mRNA on HCDCs
in culture is enhanced after stimulation with poly(I:C) and
proinflammatory cytokines
To confirm the expression of TLR3 protein on human
collecting duct epithelial cells (HCDCs), fluorescence-acti-
vated cell sorting (FACS) analysis was conducted with a
TLR3-specific monoclonal antibody as reported.30 No
detectable surface staining for TLR3 was found on HCDCs
under basal conditions. As TLR3 has been described as an
intracellular, vacuolar receptor, HCDCs were permeabilized
before TLR3 staining and FACS analysis. This resulted in a
robust TLR3 staining of HCDCs (Figure 3a).
To test whether HCDCs might express other TLRs, we
screened for mRNA of TLR1–TLR10 by real-time reverse
transcriptase-PCR (RT-PCR) under basal conditions. In
addition to TLR3, HCDCs also robustly expressed TLR1,
TLR2, TLR4, TLR5, TLR6, and TLR9. The expression for
TLR7 and TLR10 was too low to allow evaluation, and no
expression was found for TLR8 (data not shown).
To confirm TLR3 expression and to test the expression of
RIG-I protein on HCDCs, western blot analysis was
conducted with specific monoclonal antibodies for TLR3
and RIG-I (Figure 3b). Nonstimulated HCDCs revealed slight
TLR3 and moderate RIG-I basal protein expression. After
stimulation by poly(I:C) (10 mg/ml) as a mimetic of viral
dsRNA, a significant increase in the TLR3 protein expression
was observed in HCDCs, whereas RIG-I protein expression
Table 1 | TLR3/SV40 double immunofluorescence staining in PVAN biopsies
Immunofluorescence TLR3/SV40 colocalization
PVAN
case no. SV40 positivity TLR3 positivity
Medullary
collecting duct Cortex
Interstitial
infiltrates
1 +++ Strong + Few, focal ++ ++ Moderate
2 + Few, focal + Few ++++ +++ Few
3 (+) Focal ++ Moderate +++ ++++ Few, focal
4 +++ Strong + Few ++++ ++ Few
5 + Few ++ Moderate ++ + Moderate
6 +++ Strong ++ Moderate ++ ++ Moderate
7 (+) Focal + Few ++++ + Few, focal
8 (+) Focal + Few + ++ Moderate
9 (+) Focal ++ Moderate + + Moderate
10 +++ Strong +++ Strong ++++ ++++ Absent
11 + Few +++ Strong ++ + Moderate
12 +++ Strong +++ Strong +++ ++ Severe, diffuse
13 +++ Strong + Few ++ ++ Moderate
14 +++ Strong + Few +++ + Few, focal
15 +++ Strong + Few +++ +++ Absent
16 + Few + Few ++++ +++ Few, focal
17 ++ Moderate +++ Strong ++++ ++++ Few
18 ++ Moderate +++ Strong +++ ++ Severe, diffuse
19 (+) Focal ++ Moderate ++++ +++ Few, focal
Abbreviations: PVAN, polyomavirus-associated nephropathy; TLR3, Toll-like receptor 3.
TLR3/SV40 colocalization was evaluated semiquantitatively as: +, o25%; ++, X25 to o50%; +++, X50 to o75%; ++++, X75%.
Highest medullary TLR3/SV40 colocalization rates were found in PVAN biopsies with absent or few and focal interstitial infiltrates. In randomly chosen renal transplant
biopsies with negative immunohistochemical SV40 staining, TLR3 expression was nearly absent in proximal tubules, and was strong in dilated atrophic tubules.
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showed only a marginal increase. Stimulation with a
combination of proinflammatory cytokines (tumor necrosis
factor-a (TNF-a), IL-1b, and IFN-g) and 10 mg/ml poly(I:C)
enhanced both TLR3 and RIG-I expression. HEK 293 cells
were used as controls and showed a robust TLR3 and RIG-I
protein expression.
RNA was prepared from HCDCs growing under standard
conditions as well as from HCDCs that had been stimulated
with a combination of the cytokines TNF-a, IL-1b, and IFN-g
for different time intervals (0, 6, 12, 24, and 48 h). By real-
time RT-PCR, TLR3 mRNA was amplified from both
unstimulated (basal) and stimulated (comb) cells. The low
basal expression for TLR3 was significantly increased with the
cytokine combination in a time-dependent manner up to
48 h (Figure 4a). Similar results were found for RIG-I mRNA
expression (Figure 4b).
Incubation with poly(I:C) significantly increased basal
TLR3 but not RIG-I mRNA expression (Figure 4c and d)
When HCDCs had been pretreated with proinflammatory
cytokines, incubation with poly(I:C) (comb þ poly(I:C))
markedly enhanced TLR3 and RIG-I mRNA expression. This
effect was highly significant compared with basal conditions
and with cytokine-stimulated conditions (comb), respectively.
When HCDCs were stimulated with poly(I:C) in increas-
ing concentrations (1, 5, 10, and 100 mg/ml) for 12 h, under
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Figure 2 | Toll-like receptor 3 (TLR3), retinoic acid inducible
gene-I (RIG-I), and RANTES/CCL5 mRNA expression in the
tubulointerstitial compartment of manually microdissected
renal transplant biopsies. (a) Expression of mRNA for TLR3
shows a significant induction in polyomavirus-associated
nephropathy (PVAN) compared with renal allograft biopsies with
acute cellular rejection (AR) and pretransplant donor biopsies
(cadaveric donor (CD) biopsies and living donor (LD) biopsies).
(b) In renal allograft biopsies with AR, RIG-I mRNA expression
is significantly induced when compared with both controls and
biopsies with PVAN. (c) RANTES/CCL5 (regulated upon activation,
normal T cell expressed and secreted)/(chemokine (C-C motif)
ligand 5) was significantly upregulated in AR and PVAN compared
with pretransplant donor biopsies from living donors. *Po0.05;
**Po0.001.
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Figure 3 | Localization of Toll-like receptor 3 (TLR3) and
expression of TLR3 and retinoic acid inducible gene-1 (RIG-I)
in cultured human collecting duct epithelial cells (HCDCs).
(a) Localization of TLR3 protein by flow cytometry on HCDCs.
No TLR3 signal was found on HCDCs without permeabilization,
whereas a clear signal for TLR3 was detected after
permeabilization. Open histograms represent the fluorescence
activity after incubation with a monoclonal anti-TLR3 antibody
(Ab). Filled histograms denominate the signal of the appropriate
isotype control. Results shown are from one of two independent
experiments, which showed reproducible staining patterns.
(b) Western blot analysis for TLR3 and RIG-I protein expression in
HCDCs incubated with 10 mg/ml polyriboinosinic:polyribocytidylic
acid (poly(I:C)) with or without prestimulation with a combination
of proinflammatory cytokines (tumor necrosis factor-a (TNF-a),
interleukin-1b (IL-1b), and interferon-g (IFN-g)), or medium alone.
HEK 293 cells were used as positive control. Poly(I:C), mimicking
viral double-stranded RNA (dsRNA), induced TLR3 and RIG-I
protein expression. This effect was potentiated after prestimulation
with the combination of cytokines (Comb þ poly(I:C)).
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basal conditions (white columns) only a slight, and not
significant, increase for TLR3 and RIG-I was observed. In
contrast, when HCDCs were prestimulated with the cytokine
combination (black columns), the poly(I:C)-induced TLR3
and RIG-I mRNA expression was significantly increased
(Figure 4e and f). Taken together, prestimulation with a
combination of proinflammatory cytokines was an essential
prerequisite for significant TLR3/RIG-I induction.
Activation of TLR3 and RIG-I by poly(I:C) significantly
enhanced the mRNA expression of the proinflammatory
cytokine IL-6, the chemokines RANTES/CCL5, MCP-1/CCL2,
IL-8/CXCL8, and IP-10/CXCL10, and the antiviral IFN-b
To test the ‘downstream’ effects of TLR3 activation by
poly(I:C) mimicking viral dsRNA in HCDCs, we performed
real-time RT-PCR for mRNA expression of selected cytokines
and chemokines (IL-6, RANTES/CCL5, MCP-1/CCL2, IL-8/
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Figure 4 | Expression of Toll-like receptor 3 (TLR3) and retinoic acid inducible gene-I (RIG-I) mRNA on cultured human collecting duct
epithelial cells (HCDCs). HCDCs were stimulated with (Comb) or without (Basal) a combination of cytokines (tumor necrosis factor-a (TNF-a),
interleukin-1b (IL-1b), and interferon-g (IFN-g)) for the times indicated. (a) The low basal expression for TLR3 was increased with the cytokine
combination in a time-dependent manner up to 48 h. (b) Similar results were found for RIG-I mRNA expression. To test the effect of TLR3 and
RIG-I activation by polyriboinosinic:polyribocytidylic acid (poly(I:C)), mimicking viral double-stranded RNA (dsRNA), HCDCs were preincubated
with (Comb) or without (Basal) the cytokine combination (TNF-a, IL-1b, and IFN-g) and subsequently stimulated with and without poly(I:C) for
12h. The mRNA expression for TLR3 and for RIG-I was analyzed by real-time reverse transcriptase-PCR (RT-PCR). HCDCs showed low basal
expression for (c) TLR3 and (d) RIG-I mRNA, which was induced by stimulation with proinflammatory cytokines (Comb). Incubation with
poly(I:C) revealed a significant increase of basal TLR3, but not RIG-I, expression. (e, f) After pretreatment with proinflammatory cytokines, incu-
bation with different concentrations of poly(I:C) (Comb þ poly(I:C)) markedly enhanced TLR3 and RIG-I mRNA expression. *Po0.05; **Po0.01.
GAPDH, glyceraldehyde 3-phosphate dehydrogenase.
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CXCL8, and IP-10/CXCL10). HCDCs showed low basal
expression for IL-6 mRNA. IL-6 expression was significantly
induced by stimulation with proinflammatory cytokines
(comb). Incubation with poly(I:C) increased IL-6 expression
without preconditioning, an effect that was markedly
potentiated when HCDCs had been preconditioned with
proinflammatory cytokines (comb þ poly(I:C)) (Figure 5a)
in order to enhance their TLR3 expression. Similar results
were obtained for monocyte chemotactic protein-1 (MCP-1)/
CCL2 (Figure 5c) and IL-8/CXCL8 (Figure 5d). Expression of
RANTES/CCL5 (Figure 5b) could not be increased by
poly(I:C) without preconditioning, but was increased by
preconditioning with cytokines alone (comb) and even more
after cytokine preconditioning followed by additional
poly(I:C) stimulation (comb þ poly(I:C)). Basal expression
for IP-10/CXCL10 (chemokine (C-X-C motif) ligand 10)
mRNA (Figure 5e) was not detectable, and after poly(I:C)
stimulation, only a slight mRNA expression for IP-10/
CXCL10 was found. Pretreatment with the cytokine combi-
nation (comb) for 24 h resulted in a significantly increased
IP-10/CXCL10 mRNA expression, but remained similar after
additional poly(I:C) stimulation (comb þ poly(I:C)). For
8.00E–02
**
*
*
6.00E–02
4.00E–02
2.00E–02I
L-
6 
vs
.
 
G
AP
DH
0.00E+00
Ba
sa
l
Po
ly(
I:C
)
Co
m
b
Co
m
b
+
po
ly(
I:C
)
2.4E–04
**
*
8.0E–05
1.6E–04
IL
-8
 v
s. 
G
AP
DH
0.0E+00
Ba
sa
l
Po
ly(
I:C
)
Co
m
b
Co
m
b
+
po
ly(
I:C
)
6.0E–02
** *
2.0E–02
4.0E–02
IL
-6
 v
s. 
G
AP
DH
0.0E+00
Ba
sa
l
Po
ly(
I:C
)
Po
ly(
I:C
)
+
si
TL
R
3
Po
ly(
I:C
)
+
si
R
IG
-I
Po
ly(
I:C
)
+
N
T
** *
3000
6000
9000
IL
-6
 (p
g/m
l)
0
Ba
sa
l
Po
ly(
I:C
)
Po
ly(
I:C
)
+
si
TL
R
3
Po
ly(
I:C
)
+
si
R
IG
-I
Po
ly(
I:C
)
+
N
T
3.0E–05
**
**
1.0E–05
2.0E–05
IP
-1
0 
vs
.
 
G
AP
DH
0.0E+00
Ba
sa
l
Po
ly(
I:C
)
Co
m
b
Co
m
b
+
po
ly(
I:C
)
3.0E–04
4.0E–04
**
**
1.0E–04
2.0E–04
IF
N
-β 
vs
.
 
G
AP
DH
0.0E+00
Ba
sa
l
Po
ly(
I:C
)
Co
m
b
Co
m
b
+
po
ly(
I:C
)
8.0E–01
**
**
6.0E–01
4.0E–01
2.0E–01
R
AN
TE
S 
vs
.
 
G
AP
DH
0.0E+00
Ba
sa
l
Po
ly(
I:C
)
Co
m
b
Co
m
b
+
po
ly(
I:C
)
1.6E–02
**
**
1.2E–02
8.0E–03
4.0E–03
M
CP
-1
 v
s. 
G
AP
DH
0.0E+00
Ba
sa
l
Po
ly(
I:C
)
Co
m
b
Co
m
b
+
po
ly(
I:C
)
Figure 5 | Effect of polyriboinosinic:polyribocytidylic acid (poly(I:C)) and cytokine prestimulation on the mRNA expression of
selected cytokines and chemokines and short interfering RNA (siRNA) experiments for Toll-like receptor 3 (TLR3)/retinoic acid
inducible gene-I (RIG-I)-specific knockdown. Human collecting duct epithelial cells (HCDCs) were pretreated with (Comb) or without
(Basal) a cytokine combination (tumor necrosis factor-a (TNF-a), interleukin-1b (IL-1b), and interferon-b (IFN-b)) for 24 h and incubated with
or without poly(I:C) for 12 h. mRNA levels for (a) IL-6, (c) MCP-1/CCL2, (d) IL-8/CXCL8, and (e) IP-10/CXCL10, and (f) IFN-b slightly increased
after stimulation with poly(I:C). This effect was potentiated after pretreatment with the cytokine combination. (b) Expression of RANTES/
CCL5 (regulated upon activation, normal T cell expressed and secreted)/(chemokine (C-C motif) ligand 5) was not increased by poly(I:C)
without preconditioning, but was increased by preconditioning with cytokines alone (Comb) and even more after cytokine preconditioning
followed by additional poly(I:C) stimulation (Comb þ poly(I:C)). HCDCs were transfected with siRNA for TLR3 (siTLR3) or RIG-I (siRIG-I)
and were stimulated with 10 mg/ml poly(I:C) for 12 h. (g) Poly(I:C) significantly increased IL-6 mRNA expression, which was significantly
attenuated in cells pretreated with siRNA for TLR3. In contrast, siRNA for RIG-I did not significantly reduce IL-6 mRNA expression.
(h) Enzyme-linked immunosorbent assay (ELISA) for IL-6 confirmed these results. *Po0.05; **Po0.01. MCP-1, monocyte chemotactic
protein-1; NT, not transfected.
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the antiviral IFN-b, basal expression was moderately
increased after poly(I:C) stimulation, and, in parallel to the
chemokines studied afore, preconditioning with the cytokine
combination revealed a significant increase in IFN-b mRNA
expression (Figure 5f).
Knockdown of TLR3 with siRNA inhibits the poly(I:C)-induced
expression of IL-6 in cultured HCDCs, whereas knockdown of
RIG-I had no effect on IL-6 expression
Knockdown experiments using the respective short interfer-
ing RNAs (siRNAs) were conducted to evaluate which of the
two receptors (TLR3 or RIG-I) might be involved in the IL-6
cytokine response to poly(I:C) stimulation. HCDCs were
transfected with siRNA for TLR3 (siTLR3) or RIG-I (siRIG-I)
and were stimulated with 10 mg/ml poly(I:C), mimicking
viral dsRNA, for 12 h. IL-6 expression was analyzed by real-
time RT-PCR (Figure 5g) and enzyme-linked immunosor-
bent assay (ELISA; Figure 5h).
The poly(I:C)-induced IL-6 mRNA expression was
significantly attenuated in cells pretreated with siRNA for
TLR3. In contrast, siRNA for RIG-I did not significantly
reduce the poly(I:C)-induced IL-6 mRNA expression (Figure
5g). ELISA for IL-6 confirmed the poly(I:C)-induced
upregulation of IL-6 protein, which was also only attenuated
by siRNA for TLR3, but not by siRNA for RIG-I (Figure 5h).
Infection of cultured HCDCs with BKV resulted in a significant
increase of cytokine, chemokine, and TLR-3 and RIG-I
expression
HCDCs were infected with BKV as described above, to
simulate an ‘in vivo’ model of BKV infection of the distal
nephron segment, and were then incubated for different time
intervals (3, 6, 9, 12, and 24 h). As a read-out system for
effective viral infection of HCDCs, we analyzed the expres-
sion of BKV large T-Ag, representing a marker protein of the
early phase of BKV infection. Highest levels of large T-Ag
were detected at 3 h post infection by RT-PCR and decreased
in a time-dependent manner (Figure 6a). Constitutive
expression of BKV large T-Ag was still detectable 48 h after
infection, indicating active viral replication (data not shown).
Basal TLR3 and RIG-I mRNA expression showed a slight
increase during HCDC culture over 24 h. After infection of
HCDCs with BKV, the TLR3 and RIG-I mRNA expression
was upregulated markedly at 12 h, and then immediately
decreased (Figure 6b and c). The TLR3 adaptor molecule
TRIF showed a robust constitutive basal expression in
HCDCs, but BKV exposure was not able to enhance TRIF
expression in our model, as determined by RT-PCR (data not
shown). To test the potential effects of BKV infection on
selected cytokine and chemokine generation by HCDCs, we
determined IL-6 and IL-8/CXCL8 expression by RT-PCR.
Under basal conditions, HCDCs in culture showed a slight
constitutive expression of both IL-6 and IL-8.
After BKV exposure, IL-6 mRNA showed a marked
increase at 3 h and a moderate, but still highly significant,
increase 6 h after infection (Figure 6d). Similar results were
obtained for the chemokine IL-8/CXCL8 with a prominent
mRNA expression at 3 and 6 h and a return toward baseline
at 9 h post infection (Figure 6e). Corresponding protein
expression for IL-6 and IL-8/CXCL8 was demonstrated by
ELISA. In HCDCs in culture under basal conditions, we
found constitutive expression of both IL-6 and IL-8 (Figure
6f and g). After BKV exposure, IL-6 showed a significant and
robust increase at all time points, with highest absolute levels
at 9 h post infection (Figure 6f). In contrast, the chemokine
IL-8/CXCL8 was not elevated at 3 h post infection, but
showed a constant significant upregulation at 9, 12, and 24 h
after BKV infection (Figure 6g).
Infection of cultured HCDCs with BKV did not lead
to activation and upregulation of IL-1b, the NALP-3
inflammasome pathway, and AIM2
Activation of TLR3/RIG-I and robust IL-6, as well as IL-8/
CXCL8 upregulation after BKV exposure, was a consistent
feature in our ‘in vivo’ model of BKV infection. During initial
BKV infection of HCDCs, it is likely that different DNA- and
RNA-sensing pathways are triggered simultaneously, in order
to potentiate antiviral responses to infection. Recognition by
these sensing pathways could finally lead to the assembly of
inflammasome complexes that activate caspase-1, leading to
production of IL-1b and IL-18. To test this hypothesis, we
studied the expression of (1) IL-1b, an important pro-
inflammatory cytokine that is secreted after assembly of
inflammasome complexes, (2) the inflammasome compo-
nents NALP-3 and caspase-1, and (3) AIM2 (absent in
melanoma 2), a newly discovered pathogen recognition
receptor involved in the sensing of cytosolic DNA produced
by infection with DNA viruses.31–33 For IL-1b, we found no
expression under basal conditions by RT-PCR and ELISA.
After BKV infection, we found a slight, but not significant,
increase at 6 and 12 h post infection, and a significant
increase at 9 h post infection, but this marginal upregulation
could not be confirmed by ELISA technique (data not
shown). Compatible with this finding, caspase-1 and NALP-3
were absent in our model of BKV infection. AIM2 revealed a
slight constitutive expression in HCDCs, which was not
increased even after 24 h of BKV infection.
DISCUSSION
Stronger immunosuppressive regimens have decreased the
rates of AR in kidney transplantation, but have also led to the
emergence of PVAN.34 Early diagnosis of PVAN by histology
in combination with timely reduction in immunosuppression
are the only proven measures that can circumvent irreversible
parenchymal damage.35 Despite the critical role that PVAN
may have in long-term graft loss, there is surprisingly little
known about the immunology of BKV infection. In the
current study, we present results suggesting that in PVAN
viral dsRNA sensors are involved in the antiviral response.
The presence of viral dsRNA in the cell is a signature of
virus infection, which activates cellular sensors of the innate
immune system.11,36 For three reasons we evaluated the
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potential role of dsRNA sensors in PVAN. (1) Double-
stranded RNA is produced by most viruses (including
polyomavirus BK with a circular dsDNA genome) at some
point during their replication.14 (2) During promiscuous
transcription, the intracellular concentration of dsRNA is
further increased: B20% of the polyomavirus RNA in
infected cells consists of partially ds molecules during
transcription in the late stage.37,38 (3) We recently found
BKV RNA in all BKV DNA-positive biopsies, indicating
active viral replication, in a gene expression study of renal
transplant biopsies.39
DsRNA, recognized by specific dsRNA sensors, can lead to
the induction of genes associated with inflammation and an
antiviral response, including NF-kB target genes, type I IFN,
and IFN response genes. TLR3 is not universally required for
the generation of effective antiviral responses, and RNA
helicases may represent an alternative major cellular sensor
for dsRNA.40 We therefore also looked at RIG-I, which may
also function as a cytosolic alternative pattern recognition
receptor of viral motifs.9,15,41 It should be noted that a critical
cooperation of the RIG-I/MDA5-type I IFN and the TLR3-
type II IFN signaling axes may be required for efficient innate
antiviral immune responses.42
In human kidney, immunohistochemical staining shows
TLR3 expression in glomeruli with a mesangial pattern, in
vascular smooth muscle cells of preglomerular vessels, and in
collecting duct epithelial cells.30 Double immunofluorescence
staining in PVAN colocalized polyomavirus (anti-SV40) and
TLR3 protein expression particularly in epithelial cells of
medullary collecting ducts. SV40 large T-Ag showed strong
nuclear positivity in the renal epithelium, whereas TLR3
staining was most consistent with tubular intracytoplasmic
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Figure 6 | Infection of cultured human collecting duct epithelial cells (HCDCs) with BK virus (BKV) results in a significant increase
of cytokine and chemokine expression and upregulation of double-stranded RNA (dsRNA) receptors Toll-like receptor 3 (TLR3)
and retinoic acid inducible gene-I (RIG-I). HCDCs were infected with BKV and were then incubated for different time intervals (3, 6, 9,
12, and 24 h). (a) Highest levels of large T antigen (T-Ag), a marker protein of the early phase of BKV infection, were detected at 3 h post
infection by reverse transcriptase-PCR (RT-PCR) and decreased in a time-dependent manner. Basal TLR3 and RIG-I mRNA expression showed
a slight increase during incubation over 24 h. (b, c) BKV infection upregulated both receptors at 12 h post infection with a subsequent
decrease. (d) Under basal conditions, cultured HCDCs showed a low expression of interleukin-6 (IL-6) and IL-8/CXCL8, which increased
significantly after BKV exposure. (e) Similar results were obtained for the chemokine IL-8/CXCL8. (f, g) These results were confirmed
by enzyme-linked immunosorbent assay (ELISA) technique. *Po0.05; **Po0.01.
Kidney International (2012) 81, 100–111 107
A Ribeiro et al.: Innate immunity in BKV nephropathy o r ig ina l a r t i c l e
and membrane localization. Cellular inflammatory infiltrates
and mRNA expression profiles of inflammatory cytokines and
chemokines in PVAN and in AR are similar in composition
and quantity. This is particularly true for RANTES/CCL5,43
which was indeed significantly upregulated in both AR
and PVAN when compared with controls, thus confirming
relevant inflammation. TLR3 mRNA expression segregated
PVAN from AR. TLR3, but not RIG-I mRNA expression, was
significantly induced in allograft biopsies with PVAN when
compared with those with ongoing AR. In contrast, RIG-I
mRNA was selectively induced in AR, an observation
deserving further investigation.
To further elucidate a potential role of dsRNA receptors in
PVAN, we used a cell culture model of collecting tubule
origin, the predominant site of renal BK infection.5 First, we
confirmed that the immortalized HCDC line expresses
dsRNA receptors under basal conditions. A robust basal
mRNA and protein expression for TLR3, as well as for RIG-I,
was demonstrated by real-time RT-PCR and western blot
analysis. TLR3 was localized by FACS analysis in HCDCs
intracellularly. Localization of TLR3 in the endosomal
membranes of the collecting duct would expose the receptor
to the endocytosed virus during BKV infection, as discussed
above.
We prestimulated HCDCs with a cytokine combination to
establish a proinflammatory milieu in cell culture, as might
occur during viral infection. In addition, we exposed the cells
to poly(I:C), a synthetic mimetic of viral dsRNA, to simulate
aspects of viral infection. The basal expression of both TLR3
and RIG-I mRNA in HCDCs was increased by prestimulation
with the combination of cytokines in a dose-dependent
manner. The expression of TLR3 and RIG-I mRNA was also
enhanced after stimulation with poly(I:C). The concentration
of poly(I:C) required for these effects is in the range of those
reported by others for these receptors.44
Human tubular epithelial cells are known to interact with
both neighboring cells and the immune system through the
production of cytokines and chemokines such as IL-6, IL-8,
IL-15, TNF-a, MCP-1, RANTES, and TGF-b.45–47 These
responses are required to initiate a cellular and humoral
immune response to control infection, but can also result in
tissue injury and dysfunction, as evidenced in PVAN.6
Activation of viral receptors by poly(I:C) significantly
enhanced the mRNA expression of various cytokines and
chemokines (IL-6, IL-8/CXCL8, RANTES/CCL5, MCP-1/
CCL2, and IP-10/CXCL10) in HCDCs after poly(I:C)
stimulation. These findings are in accordance with data from
Mannon et al.,43 who reported elevated levels of RANTES,
TNF-a, TNF-b, and activation markers of macrophages in
PVAN. In addition, increased urinary excretion of MCP-1 is
associated with intragraft tubulointerstitial inflammation in
patients with PVAN.48
To identify which viral receptors might contribute to the
generation of cytokines and chemokines, we knocked down
the receptor expression. The poly(I:C)-induced expression of
IL-6 was significantly inhibited by transfection with siRNA
for TLR3, whereas transfection with siRNA for RIG-I had no
significant effect on IL-6, suggesting a pivotal role of TLR3 in
this scenario.
Finally, we established an infection model using cultured
HCDCs and BKV. After BKV infection, the mRNA expression
for IL-6 and IL-8/CXCL8 increased. This early cytokine and
chemokine activation was followed by a time-dependent
significant increase of TLR3 and RIG-I expression with
maxima at 12 h post infection, whereas BKV infection could
not further enhance the robust constitutive basal expression
of TRIF. Recently, primary human proximal tubule epithelial
(HPTE) cells were described as a model for lytic BKV
infection.49 Subsequent studies found a primary activation of
genes involved in cell cycle regulation and apoptosis.50 Of
particular note, the HPTE model was not able to elicit an
antiviral immune response in the given experimental context.
Our results differ in two major points from the HPTE
model: First, in HCDCs, we demonstrated a significant
expression of large T-Ag, a marker protein of the early phase
of BKV infection, at a very early stage of infection (3 h post
infection), whereas in the HPTE model early viral gene
expression was first detectable at 24 h post infection with
levels increasing out to 72 h. This finding suggests that BKV
infection of HCDCs involves particularly the early phase of
BKV infection with a more rapid viral trafficking through the
cytoplasm than in HPTE cells. Second, the distinctive
cytokine and chemokine activation after BKV infection was
a prominent early signature in our model. In contrast, a
cytokine-targeted PCR array analysis of the HPTE model
performed at 4 h post infection revealed no proinflammatory
response to BKV infection.50
Even basal TLR3 and TRIF expression was sufficient for
significant early cytokine/chemokine activation in our infec-
tion model. This early activation seems to be independent of
efficient virus replication, as demonstrated also in, for example,
rhinovirus-induced airway epithelial cells,51,52 and apparently
kick-starts an efficient antiviral response in HCDCs, leading to
a transient robust dsRNA receptor expression as demonstrated
by significant TLR3 and RIG-I expression.
Activation of TLR3 and RIG-I after stimulation with
synthetic dsRNAwas a consistent feature in cultured HCDCs,
and upregulation of both receptors was confirmed in our
infection model mimicking the early infection phase of the
collecting duct by BKV. In contrast, we found a robust TLR3,
but unexpectedly no significant RIG-I expression in biopsies
with PVAN. How can this obvious discrepancy be reconciled?
During initial BKV infection of HCDCs, it is likely that
different DNA- and RNA-sensing pathways are triggered
simultaneously, leading to a parallel upregulation of various
receptors. This cross talk between different innate immunity
pathways could eventually potentiate antiviral responses to
infection. Other potential pathways have been recently
suggested,53,54 but we were not able to demonstrate
activation/upregulation of IL-1b, the NALP-3 inflammasome
pathway, or AIM2 in our newly established ‘in vivo’ model of
BKV infection of the distal nephron segment.
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A detailed analysis of the observed differences in dsRNA
receptor activation between PVAN and AR should now be an
important area of future study and could also have a
significant impact on the demanding histological differentia-
tion of these two inflammatory conditions. The striking
upregulation of RIG-I mRNA expression in AR has now to be
confirmed in larger-scale studies and with immunohisto-
chemical or immunofluorescence techniques. On the basis of
our findings, it is questionable whether TLR3 mRNA
expression analysis or TLR3 immunohistochemistry has the
potential to serve as an additional diagnostic tool to
discriminate PVAN biopsies from those with acute ongoing
rejection, as TLR3 expression is not a unique feature of
PVAN. Although TLR3 immunofluorescence signals were
most intense in medullary collecting ducts of PVAN, and
were independent of concomitant inflammation, we also
observed distinct TLR3 staining in cortical atrophic and
dilated tubules of AR.
Taken together, we were able to show significant activation
of proinflammatory cytokines, chemokines, and the dsRNA
receptors TLR3 and RIG-I in cultured HCDCs after poly(I:C)
and cytokine stimulation and in a BKV infection model,
mimicking polyomavirus BK infection of collecting duct
tubules. Immunofluorescence double staining of BKV and
TLR3 and mRNA expression analysis of biopsies with PVAN
suggest that activation of innate immune defense mecha-
nisms particularly via TLR3 are involved in the antiviral and
inflammatory response.
MATERIALS AND METHODS
Preparation of human tissue
For mRNA expression analysis, parts of human renal biopsies were
obtained according to the directives of the local ethical committees,
and samples were processed according to the protocol of a European
multicenter study for gene expression analysis (the European Renal
cDNA Bank–Kroener-Fresenius Biopsy Bank (ERCB-KFB)).55 Micro-
dissected tubulointerstitial specimens from 21 patients were analyzed,
including 10 allograft biopsies with acute cellular rejection and 5
allograft biopsies with PVAN. In both groups the Banff histological
scores and the immunohistochemical analysis of inflammatory
infiltrates were similar. For control biopsies, renal tissue was derived
from pretransplantation kidney biopsies during cold ischemia time
from three cadaveric (CON CDx, n¼ 3) and three living donors
(CON LDx, n¼ 3).
For double immunofluorescence staining, paraffin-embedded
tissue sections from a total of 23 renal allografts, including 19 cases
with a histological secured diagnosis of PVAN and 4 randomly
chosen transplant biopsies with AR, were obtained from the
Department of Cellular and Molecular Pathology at the German
Cancer Research Center following guidelines of the respective Ethics
Committees.
Immunofluorescence technique for TLR3 and SV40 double
staining
For immunofluorescence double staining, 5 mm sections were
prepared and mounted on glass slides. After microwave antigen
retrieval with citrate buffer, we treated the specimens with blocking
buffer and subsequently with primary antibodies against SV40 (1:20;
mouse T-Ag; Calbiochem, San Diego, CA) or TLR3 (1:100; anti-
human guinea pig), followed by species-specific secondary anti-
bodies as recently described.56 Specimens were analyzed on a Leica
SP5 (Solms, Germany) confocal microscope and confocal stacks
were modeled using the Volocity software (Waltham, MA).
Cell culture of immortalized HCDCs
Immortalized HCDCs, provided by H Debiec,57 were grown in
culture medium containing a 1:1 mixture of Dulbecco’s modified
Eagle’s medium and Ham’s F12 medium supplemented with 5 mg/ml
insulin (Sigma, Taufkirchen, Germany), 5 108mol/l dexametha-
sone (Sigma), 3 108mol/l sodium selenite (Sigma), 5 mg/ml trans-
ferrine (Sigma), 2mmol/l glutamine (Gibco, Karlsruhe, Germany),
10mol/l HEPES Buffer (Gibco), and 2% heat-inactivated fetal
bovine serum.
For ELISA and RNA extraction, HCDCs were incubated with a
combination of TNF-a (25 ng/ml), IL-1b (10 ng/ml), and IFN-g
(20 ng/ml) for 24 h, washed with phosphate-buffered saline (PBS),
incubated in culture medium for 6 h, and washed again with PBS.
Subsequently, HCDCs were incubated with medium alone (control)
or medium containing poly(I:C) (10 mg/ml) for 12 h. Aliquots of the
supernatant medium were removed for ELISA analysis at the time
points indicated. For analysis of mRNA levels, extraction of total
RNA was performed using an RNeasy Mini Kit (Qiagen, Hilden,
Germany) with additional DNase digestion.
Quantitative real-time RT-PCR analysis
Real-time RT-PCR analysis was performed on a TaqMan ABI
7700 sequence detection system (Applied Biosystems, Darmstadt,
Germany) using heat-activated TaqDNA polymerase (Amplitaq
Gold; Applied Biosystems) as described previously.55 Commercially
available predeveloped TaqMan reagents were used for the human
target genes (TLR3, gene bank accession number NM_003265/
U88879; RIG-I, NM_014314; IL-6, NM_000600; RANTES/CCL5,
AF043341; MCP-1/CCL2, X14768; IL-8/CXCL8, Z11686; IP-10/
CXCL10, NM_001565; TRIF, Hs01090712_m1; IL-1b, XM010760;
caspase-1, Hs00354836_m1; NALP3, Hs00918082_m1; AIM2,
Hs00175457_m1) and two endogenous control genes (18S rRNA,
4310893E; GAPDH, M33197; Applied Biosystems). The normal-
ization to both reference (housekeeping) genes yielded comparable
results. For detection of BKV large T-Ag sequence, the following
primer pair was used: forward: 50-GGAAAGTCTTTAGGGTCT
TCTACCTTT-30; reverse: 50-GGTGCCAACCTATGGAACAGA-30;
specific probe: 50-AATCTGCTGTTGCTTCTTCATCACTGGCA-30,
FAM and TAMRA labeled.31 All measurements were recorded in
duplicates. Controls consisting of bidistilled H2O were negative in
all runs.
FACS analysis for TLR3
For FACS analysis, cultured HCDCs were detached with PBS/
10mmol/l EDTA (pH 8) and stained for TLR3 using a specific
mouse monoclonal antibody (eBioscience, San Diego, CA) and a
fluorescein isothiocyanate rabbit secondary antibody against mouse
F(ab)2 fragment (F0232; Dako, Glostrup, Denmark) as described.
30
For intracellular staining, HCDCs were treated with Cytofix/
Cytoperm Reagent (BD Biosciences, San Jose, CA) followed by
monoclonal antibody against TLR3 and secondary antibody
incubations in saponin buffer. The TLR3 signal was analyzed using
a FACSCalibur with CellQuest analysis software (Becton-Dickinson,
Heidelberg, Germany). Appropriate IgG isotype preparations
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(mouse IgG1 clone MOPC 21, Sigma) were used to control for
unspecific staining.
Western immunoblot analysis for TLR3 and RIG-I
After incubation with poly(I:C) with or without prestimulation with
proinflammatory cytokines, HCDCs were lysed with radioimmu-
noprecipitation assay buffer (50mmol/l Tris-HCL, pH 8; 150mmol/l
NaCl; 1% NP-40; 0.5% sodium deoxycholate; 0.1% SDS) containing
protease inhibitors. The lysates were cleared by centrifugation at
13,000 g for 15min at 4 1C and protein concentration was
determined with the DC protein assay kit (Bio-Rad Laboratories,
Munich, Germany). Proteins (40 mg/ml) were separated by sodium
dodecyl sulfate-polyacrylamide on an 8% polyacrylamide gel and
transferred to a polyvinylidene fluoride membrane for western
blotting (Immobilon-P Transfer Membrane; Millipore, Schwalbach,
Germany). The membranes were blocked in 3% milk solution in
Tris-buffered saline/Tween 20 (TLR3) or 5% bovine serum albumin
(RIG-I) for 1 h and probed overnight with a monoclonal antibody
against human TLR3 (Acris Antibodies, Hiddenhausen, Germany)
or human RIG-I provided by Dr Simon Rothenfusser.58
After washing four times in Tris-buffered saline with Tween-20,
the membranes were incubated with secondary purified rabbit anti-
mouse IgG (H&L)-HRP (TLR3) or secondary peroxidase-conju-
gated AffiniPure Goat Anti-Rat IgGþ IgM (Hþ L) (RIG-I) for 1 h
and washed again four times with Tris-buffered saline with Tween-
20. Signals were visualized with a Western Lightning Chemilumi-
nescence reagent plus Kit (Perkin Elmer, Waltham, MA).
ELISA
ELISAs for IL-6, IL-8, and IL-1b were performed on cell culture
supernatants using commercial assay kits (Quantikine, R&D
Systems, Minneapolis, MN) following the provider’s instructions.
Knockdown of gene expression with siRNA
Predesigned siRNA for TLR3 and RIG-I was purchased from
Ambion (Tokyo, Japan). Transfection of siRNA into the cells was
performed over 24 h as described.59 Scrambled siRNA was used as
the nonspecific negative control of siRNA (Ambion).
Polyomavirus BK preparation and infection of HCDCs with
polyomavirus (type BK) derived from patients with BKV
reactivation
For BK virus isolation, a urine sample with a viral load of 4108
copies/ml from a patient with a known BKV reactivation was used.
The sample was inoculated for 1 h on Vero cells before minimal
essential medium/2% fetal calf serum was added. Viral propagation
was monitored in the supernatant by quantitative real-time PCR
with an in-house test on a 7500 Fast Real-Time PCR System
(Applied Biosystems, Darmstadt, Germany) using primers from the
large T-Ag region and a VIC-labeled probe (see above). At a load of
109 copies/ml, virus was harvested by centrifugation of the
supernatant and subsequently passaged on HEK 293 cells with
minimal essential medium/2% fetal calf serum for 60 days. Infected
cells were split at 10-day intervals. Viral growth was monitored by
quantitative PCR and by immunofluorescence against T-Ag (Abcam,
Cambridge, MA). To isolate BKV, HEK 293 cells were lysed by
repeated freeze–thaw cycles (three times) and subsequent centrifuga-
tion at 800 g for 30min. The supernatant was adjusted to 5000
focus-forming units per ml with PBS and stored at 80 1C. For
experiments, virus was dissolved in culture medium and HCDCs
were stimulated as indicated (1ml medium per well).
Statistical analysis
Values are provided as mean±s.e.m. Statistical analysis was
performed by unpaired t-test if applicable or by analysis of variance.
Significant differences are indicated for P-values o0.05 (*) or 0.01
(**), respectively.
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